# Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/exenatide-once-weekly-versus-twice-daily-for-the-treatment-of-type-2-diabetes-a/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Daniel J. Drucker,John B. Buse,Kristin Taylor,David M. Kendall,Michael Trautmann,Dongliang Zhuang,Lisa A. Porter |
| Citations | 1,070 |
| DOI | 10.1016/s0140-6736(08)61206-4 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2138077952 |
| PMID | 18782641 |
| Type | article |
| Year | 2008 |

## Paper authors

- [David M. Kendall](https://scholariq.org/researchers/david-m-kendall/)
- [John B. Buse](https://scholariq.org/researchers/john-b-buse/)

## Paper journal

- [The Lancet](https://scholariq.org/journals/the-lancet/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Bariatric Surgery and Outcomes](https://scholariq.org/topics/bariatric-surgery-and-outcomes/)
- [Hyperglycemia and glycemic control in critically ill and hospitalized patients](https://scholariq.org/topics/hyperglycemia-and-glycemic-control-in-critically-ill-and-hospitalized-patients/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.